These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. How I treat the co-occurrence of venous and arterial thromboembolism: anticoagulation, antiplatelet therapy, or both? May JE; Moll S Blood; 2024 Jun; 143(23):2351-2362. PubMed ID: 38364188 [TBL] [Abstract][Full Text] [Related]
7. Hypercoagulable states in arterial and venous thrombosis: When, how, and who to test? Carroll BJ; Piazza G Vasc Med; 2018 Aug; 23(4):388-399. PubMed ID: 30045685 [TBL] [Abstract][Full Text] [Related]
8. Hypercoagulability and nephrotic syndrome. Gigante A; Barbano B; Sardo L; Martina P; Gasperini ML; Labbadia R; Liberatori M; Amoroso A; Cianci R Curr Vasc Pharmacol; 2014 May; 12(3):512-7. PubMed ID: 22724465 [TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid syndrome - an update. Linnemann B Vasa; 2018 Oct; 47(6):451-464. PubMed ID: 30205764 [TBL] [Abstract][Full Text] [Related]
10. Management of the antiphospholipid syndrome. DeMarco P; Singh I; Weinstein A Curr Rheumatol Rep; 2006 Apr; 8(2):114-20. PubMed ID: 16569370 [TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of Thrombosis in Peripheral Artery Disease. Habib A; Petrucci G; Rocca B Curr Vasc Pharmacol; 2020; 18(3):204-214. PubMed ID: 30727897 [TBL] [Abstract][Full Text] [Related]
12. Evolving concepts in the pathogenesis and treatment of arterial thrombosis. Chesebro JH; Toschi V; Lettino M; Gallo R; Badimon JJ; Fallon JT; Fuster V Mt Sinai J Med; 1995 Sep; 62(4):275-86. PubMed ID: 7565850 [No Abstract] [Full Text] [Related]
13. Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease. Gurbel PA; Fox KAA; Tantry US; Ten Cate H; Weitz JI Circulation; 2019 Apr; 139(18):2170-2185. PubMed ID: 31034291 [TBL] [Abstract][Full Text] [Related]
14. Thrombotic complications resulting from hypercoagulable states in chronic hemodialysis vascular access. LeSar CJ; Merrick HW; Smith MR J Am Coll Surg; 1999 Jul; 189(1):73-9; discussion 79-81. PubMed ID: 10401743 [TBL] [Abstract][Full Text] [Related]
16. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged? Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123 [TBL] [Abstract][Full Text] [Related]
17. New approaches to inhibiting platelets and coagulation. Depta JP; Bhatt DL Annu Rev Pharmacol Toxicol; 2015; 55():373-97. PubMed ID: 25562644 [TBL] [Abstract][Full Text] [Related]
18. Thrombotic disorders: diagnosis and treatment. Schafer AI; Levine MN; Konkle BA; Kearon C Hematology Am Soc Hematol Educ Program; 2003; ():520-39. PubMed ID: 14633797 [TBL] [Abstract][Full Text] [Related]
19. How I treat patients with inherited bleeding disorders who need anticoagulant therapy. Martin K; Key NS Blood; 2016 Jul; 128(2):178-84. PubMed ID: 27106121 [TBL] [Abstract][Full Text] [Related]
20. Blood viscosity and thrombosis: clinical considerations. Smith BD; La Celle PL Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]